Cellectar Biosciences (NV40) Q2 2024 Earnings Report
DE:NV40 Q2 2024 EPS Results
- Actual EPS
- -EUR 4.84
- Consensus EPS
- -EUR 8.60
- Beat/Miss
- Beat by +EUR 3.76
- One Year Ago EPS
- -EUR 19.61
DE:NV40 Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/13/2024
- Time
- Before Open
- Conference Call
- Tuesday, August 13, 2024
DE:NV40 Upcoming Earnings
Cellectar Biosciences's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:NV40 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NV40 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -0.50- | -1.26 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.47-0.51 | -3.04 | 83.19% (+2.53) | |
| May 14, 2026 | 2026 (Q1) | -1.69-1.19 | -3.76 | 68.33% (+2.57) | |
| Mar 04, 2026 | 2025 (Q4) | -1.100.58 | -1.88 | 130.95% (+2.46) | |
| Nov 13, 2025 | 2025 (Q3) | -2.26-1.26 | -10.74 | 88.25% (+9.48) | |
| Aug 14, 2025 | 2025 (Q2) | -3.33-3.04 | -4.84 | 37.22% (+1.80) | |
| May 13, 2025 | 2025 (Q1) | -4.39-3.76 | -19.88 | 81.08% (+16.12) | |
| Mar 13, 2025 | 2024 (Q4) | -9.47-1.88 | -11.01 | 82.93% (+9.13) | |
| Nov 18, 2024 | 2024 (Q3) | -8.86-10.74 | -23.35 | 53.99% (+12.61) | |
| Aug 13, 2024 | 2024 (Q2) | -8.60-4.84 | -19.61 | 75.34% (+14.77) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
